A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer. (Q40330401)
scientific article published on 27 April 2006
Language:
(P31) (Q13442814)
(P50) (Q37829209)
(Q57002381)
(Q60621635)
(P304) 79-87
(P407) (Q1860)
(P433) 1
(P478) 59
(P577) Thursday, April 27, 2006
(P921) (Q643839)
(Q323936)
(P1433) (Q326137)
(P1476) "A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer" (language: en)
(P2093) O'Leary M
Ballot J
Collins CD
Kinsella P
Mager DE
Larkin A
Kennedy S
Fennelly D
Clynes M
Crown J
(P2860) (Q26778382)
(Q33183406)
other details
description scientific article published on 27 April 2006

External Links